Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAOMI: Heroin-Assisted Therapy for Treatment-Refractory Injection Opiate Users
NCT00175357Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diamorphine in opioid use disorder (OUD), sponsored by University of British Columbia. Started Mar 2005; status: completed.
02
Drugs
diamorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00175357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175357.